Canadian Online Pharmacy

CDER New September 19, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

September 18, 2014


New and Generic Drug Approvals

September 17, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Amoxapine amoxapine Tablet;Oral Watson Labs Labeling Revision
Citalopram Hydrobromide citalopram hydrobromide Solution;Oral Roxane Labeling Revision
Daliresp roflumilast Tablet;Oral Forest Res Inst Inc Manufacturing Change or Addition
Dextrose 5% and Sodium Chloride 0.45% In Plastic Container dextrose; sodium chloride Injectable;Injection Hospira Manufacturing Change or Addition
Docetaxel docetaxel Injectable;Injection Actavis Inc Labeling Revision
Lactated Ringer's In Plastic Container calcium chloride; potassium chloride; sodium chloride; sodium lactate Injectable;Injection Hospira Manufacturing Change or Addition
Serostim somatropin recombinant Injectable;Injection Emd Serono Manufacturing Change or Addition
Serostim Lq somatropin recombinant Injectable;Subcutaneous Emd Serono Manufacturing Change or Addition
Sodium Chloride 0.45% In Plastic Container sodium chloride Injectable;Injection Hospira Manufacturing Change or Addition
Sodium Chloride 0.9% In Plastic Container sodium chloride Injectable;Injection Hospira Manufacturing Change or Addition
Stendra avanafil Tablet;Oral Vivus Efficacy Supplement with Clinical Data to Support
Tofranil imipramine hydrochloride Tablet;Oral Mallinckrodt Inc Labeling Revision
Venlafaxine Hydrochloride venlafaxine hydrochloride Tablet;Oral Teva Labeling Revision
Vivactil protriptyline hydrochloride Tablet;Oral Odyssey Pharms Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery